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Abstract
Bile acid-induced inhibition of DNA synthesis by the regenerating rat liver in the absence of other manifestation of
impairment in liver cell viability has been reported. Because in experiments carried out on in vivo models bile acids are
rapidly taken up and secreted into bile, it is difficult to establish steady concentrations to which the hepatocytes are exposed.
Thus, in this work, a dose^response study was carried out to investigate the in vitro cytotoxic effect of major unconjugated
and tauro- (T) or glyco- (G) conjugated bile acids and to compare this as regards their ability to inhibit DNA synthesis.
Viability of hepatocytes in primary culture was measured by Neutral red uptake and formazan formation after 6 h exposure
of cells to bile acids. The rate of DNA synthesis was determined by radiolabeled thymidine incorporation into DNA.
Incubation of hepatocytes with different bile acid species ^ cholic acid (CA), deoxycholic acid (DCA), chenodeoxycholic acid
(CDCA) and ursodeoxycholic acid (UDCA), in the range of 10^1000 WM ^ revealed that toxicity was stronger for the
unconjugated forms of CDCA and DCA than for CA and UDCA. Conjugation markedly reduced the effects of bile acids on
cell viability. By contrast, the ability to inhibit radiolabeled thymidine incorporation into DNA was only slightly lower for
taurodeoxycholic acid (TDCA) and glycodeoxycholic acid (GDCA) than for DCA. When the effect of these bile acids on
DNA synthesis and cell viability was compared, a clear dissociation was observed. Radiolabeled thymidine incorporation
into DNA was significantly decreased (350%) at TDCA concentrations at which cell viability was not affected. Lack of a
cause^effect relationship between both processes was further supported by the fact that well-known hepatoprotective
compounds, such as tauroursodeoxycholic acid (TUDCA) and S-adenosylmethionine (SAMe) failed to prevent the effect of
bile acids on DNA synthesis. In summary, our results indicate that bile acid-induced reduction of DNA synthesis does not
require previous decreases in hepatocyte viability. This suggests the existence of a high sensitivity to bile acids of cellular
mechanisms that may affect the rate of DNA repair and/or proliferation, which is of particular interest regarding the role of
bile acids in the etiology of certain types of cancer. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Bile acids are endogenous compounds with deter-
gent properties, which at high concentrations have
deleterious e¡ects upon cell membranes. However,
at low concentrations, at which they are present in
aqueous solutions as monomeric molecules and are
not able to solubilize membrane lipids, e¡ect on cell
viability has been also reported [1]. Modi¢cations in
several cell functions may be mediated by the e¡ects
of bile acids on intracellular signaling mechanisms
[2^4] and membrane permeability [5]. Additionally,
from studies carried out on isolated perfused rat liv-
er, we have previously shown the ability of certain
bile acids to modify DNA synthesis during rat liver
regeneration [6]. This was observed in the absence of
signs of reduced liver viability, as assessed by meas-
urements of bile £ow, oxygen uptake, perfusion pres-
sure, perfusion £ow and release into the perfusate of
potassium and lactate dehydrogenase. The cytotoxic-
ity of bile acids has been associated with the lipid
peroxidation capacity [7] and, in an inverse manner,
with the degree of lipophilicity [8,9] of the di¡erent
molecular species. Important di¡erences in the ability
of molecular species of bile acids to modify DNA
synthesis have been observed in vivo with no varia-
tions in toxicity tests [10]. However, this e¡ect does
not seem to be directly related to the hydrophobic/
hydrophilic bile acid balance. The inhibitory ability
is shared by most unconjugated and tauroconjugated
bile acids, but, this is somehow abolished by conju-
gation with glycine [10]. Inhibition of thymidine kin-
ase activity has been suggested to play a role in the
e¡ect of tauroconjugated and unconjugated bile acids
on DNA synthesis by regenerating rodent liver
[11,12], although other alternatives cannot be ruled
out. Some biological e¡ects of bile acids that can
potentially a¡ect the replicative process have been
described: alterations in intracellular calcium levels
have been reported to occur during incubation of
isolated hepatocytes with certain bile acids [2].
Some bile acids have been found to induce Na/H
exchange activation [3], which can a¡ect the overall
e¥ux of these ions across the plasma membrane and
hence the intracellular pH [13]. There is increasing
experimental evidence supporting the hypothesis of
a genotoxic e¡ect of bile acids [14,15] and their ca-
pacity to modify some components of the complex
signaling involved in the control of cell proliferation
and apoptosis [4].
Several interesting questions regarding the e¡ect of
bile acids on DNA synthesis remain unanswered.
One of them is whether the di¡erent e¡ect of bile
acid species is due to di¡erences in their dynamic
of uptake and secretion into bile, which accounts
for di¡erent intrahepatocyte residence time, or to
di¡erent inhibitory properties of these compounds.
Finally, although suggested by previous in vivo stud-
ies, whether a non-selective impairment in hepatocyte
function is mandatory for bile acid-induced reduc-
tion in DNA synthesis has not been proved. The
aim of the present study was therefore to compare
the e¡ect of bile acids on cell viability with their
ability to reduce DNA synthesis by rat hepatocytes
in primary culture in order to answer these questions.
2. Materials and methods
2.1. Chemicals
Collagenase (type IV), bovine serum albumin
(fraction V), calf thymus DNA, Hoechst-33258, Neu-
tral red, Williams’ medium E, dexamethasone, insu-
lin, ethanolamine, HEPES, epidermal growth factor
(EGF), transferrin, linoleic acid, galactose, ornithine,
nicotinamide, thymidine, Trypan blue, S-adenosyl-
methionine (SAMe), antibiotic and antimycotic mix-
ture (penicillin, streptomycin and amphotericin) and
bile acids or sodium bile salts were purchased from
Sigma (St. Louis, MO), except for glycoursodeoxy-
cholic acid, which was from Calbiochem (San Diego,
CA). Bile acids were more than 95% pure by thin-
layer chromatography. [Methyl-14C]thymidine (spe-
ci¢c activity 60 mCi/mmol) was from Amersham
Pharmacia Biotech (Buckinghamshire, UK). All oth-
er chemicals were from Merck (Darmstadt, Ger-
many).
2.2. Isolation and culture of rat hepatocytes
Male Wistar CF rats (180^200 g, Animal House,
University of Salamanca, Spain) were used as donors
to obtain rat hepatocytes. The animals were fed on
commercial-pelleted rat food (Panlab, Madrid,
Spain) and had free access to food and water. Light-
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ing was controlled by a timer that permitted light
between 08.00 and 20.00 h. All animals received hu-
man care as outlined in ‘Guide for the Care and Use
of Laboratory Animals’ (NIH Publication 80-23, re-
vised 1985). The rats were fasted for 24 h before
hepatocyte isolation. This was carried out by a mod-
i¢cation of Berry’s procedure [16]. The rats were
anesthetized by i.p. administration (5 mg/100 g
b.wt.) of sodium pentobarbital (Nembutal, Abbott,
Madrid, Spain). The liver was perfused using a prep-
aration similar to that described [17]. Non-recirculat-
ing perfusion was carried out through the portal vein
with calcium-free phosphate bu¡er saline (PBS,
137 mM NaCl, 3 mM KCl, 0.5 mM Na2HPO4,
1.5 mM KH2PO4) for 10 min at 40 ml/min. After-
wards, the perfusate was changed to a solution con-
taining collagenase in a recirculating system for
8 min. Once the surface of the liver had become
soft, the whole organ was removed and cells were
released into the collagenase solution by gentle dis-
persion of the tissue. The cell suspension was diluted
with 1.0 mM calcium-containing PBS and ¢ltered
sequentially through three sizes of nylon mesh (500,
140 and 80 Wm pore size). Cells were pelleted by
three sequential centrifugations (43Ug for 2 min).
After this, the cells were resuspended in attachment
medium; Williams’ medium E supplemented with 10
mM HEPES, 26.2 mM NaHCO3, 100 nM Na2SO3,
30 nM dexamethasone, 100 nM insulin and 11.1 mM
galactose, pH 7.4. Initial viability was determined by
the Trypan blue dye exclusion method and was al-
ways higher than 90%. Finally, hepatocytes were
seeded on rat tail collagen-coated plates at densities
between 1.5U104 and 3U104 cells/cm2. After 90 min
incubation at 37‡C in an atmosphere of 5% CO2^
95% air, the medium was replaced by fresh Williams’
medium E supplemented with 10 mM HEPES, 26.2
mM NaHCO3, 100 nM Na2SO3, 30 nM dexametha-
sone, 100 nM insulin, 11.1 mM galactose, 5 nM
EGF, 1 WM ethanolamine, 5 Wg/ml transferrin, 5 Wg/
ml linoleic acid, 0.5 mg/ml fatty acid-free albumin,
10 mM nicotinamide, and 6 mM ornithine, which
was used to culture the cells for up to 3 days.
2.3. Experimental protocol
DNA synthesis under the experimental conditions
used in this work was measured at di¡erent times of
culture (Fig. 1). This permitted us to establish ad-
equate timing for the rest of experiments described
below. To investigate the e¡ect of unconjugated,
tauroconjugated and glycoconjugated forms of the
major bile acid species on cell viability, the culture
medium was replaced by a fresh one containing none
(control) or one of the tested bile acids in the range
of 10^1000 WM ¢nal concentration. After 6 h expo-
sure to this solution, cell viability was measured by
the Neutral red uptake assay and/or the formazan
formation test. The e¡ect of bile acids on DNA syn-
thesis was studied in di¡erent culture dishes in which
both the bile acid and radiolabeled thymidine were
added 6 h before cell harvesting. This was carried out
at 48 h of culture.
2.4. Analytical methods
A modi¢cation of the Fautz method was used to
carry out Neutral red uptake assay [18]. In brief, a
¢nal Neutral red concentration of 50 Wg/ml in sterile
PBS was used. This solution was prewarmed to 37‡C
before its use. The cells were washed once with PBS
(37‡C) to remove non-adherent and dead cells. This
was replaced by Neutral red-containing medium. The
cultures were incubated for 90 min at 37‡C in an
atmosphere of 5% CO2^95% air allowing the lyso-
somes and Golgi apparatus of viable cells to take
up the dye. The cultures were then carefully washed
with Neutral red-free PBS to eliminate remaining
extracellular dye. The incorporated Neutral red was
eluted from the hepatocytes with 50% ethanol sup-
plemented with 1% acetic acid for 10 min. Absorb-
ance at 540 nm of the eluate was measured. Tetra-
zolium salts are metabolically reduced to highly
colored end products called formazans [19]. Forma-
zan formation by rat hepatocyte was measured using
a water soluble tetrazolium compound 3-(4,5-di-
methylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium and an electron cou-
pling reagent (phenazine methosulfate) as part of a
commercial kit (CellTiter 96AQ, Promega, Madison,
WI) according to an adaptation of the supplier’s in-
structions for use. Proteins were determined by a
modi¢cation of the Lowry method [20] using serum
bovine albumin as standard. DNA measurements
were carried out using Hoechst-33258 as £uorescent
probe [21], and calf thymus DNA as standard. DNA
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synthesis was measured by [methyl-14C]thymidine in-
corporation into DNA as previously described [22].
Rates of [methyl-14C]thymidine incorporation into
DNA were normalized per milligram of cellular pro-
tein or per microgram of cellular DNA.
2.5. Statistical analysis
Experiments were carried out on four di¡erent cul-
tures in which each concentration- or time-point was
calculated from measurements obtained from three
di¡erent plates. Results are expressed as means þ S.E.
For calculating the statistical signi¢cance of di¡er-
ences within or among the groups the paired t-test
or the Bonferroni method of multiple-range testing
were used, as appropriate. Statistical analysis was
performed on a Macintosh LC-III computer (Apple
Computer, Cupertino, CA) with programs supplied
by Apple Computer.
3. Results
Following a lag time of approximately 24 h, rat
hepatocytes cultured under the experimental condi-
tions described in Section 2 started to synthesize
DNA, as indicated by the increase in thymidine in-
corporation into DNA and in the total amount of
DNA in the culture (Fig. 1). Both parameters kept
increasing up to the end of the studied period (72 h).
Fig. 2. Dose-dependent e¡ect of the unconjugated (open
circles), tauro-conjugated (¢lled squares) and glyco-conjugated
forms (open squares) of the following bile acids: cholic acid
(CA), deoxycholic acid (DCA), chenodeoxycholic acid (CDCA)
and ursodeoxycholic acid (UDCA), on cell viability as meas-
ured by Neutral red uptake after 6 h exposure to the indicated
bile acid. Values (means þ S.E., four experiments carried out in
triplicate) are expressed as percent of mean value found in the
control group (cells cultured in the absence of bile acids). Re-
sults were compared with control culture conditions by the
paired t-test (2P6 0.05) and among bile acids species by the
Bonferroni method of multiple range testing (*P6 0.05).
Fig. 1. Time course of rat hepatocyte growth in primary cul-
ture. (A) Radiolabeled thymidine incorporation into DNA. (B)
Total amount of DNA in the culture. Values are means þ S.E.
(four experiments carried out in triplicate).
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An intermediate time-point between 24 and 72 h (42^
48 h of culture), in which DNA synthesis was as-
sumed to be very active, was selected to carry out
exposure to bile acids in subsequent experiments.
Cell viability after 6 h exposure to the glycoconju-
gated, tauroconjugated and unconjugated forms of
the major bile acid species was tested. Among the
bile acid species included in this study, CA and
UDCA were found to be those inducing the lowest
reduction in cell viability. Only at concentrations
higher than 500 WM CA or UDCA, a signi¢cant
decrease in Neutral red uptake was found (Fig. 2).
This e¡ect was slightly stronger for UDCA, which at
1000 WM signi¢cantly reduced cell viability, regard-
less of its conjugation state. By contrast, for CA,
toxicity was only observed for the glycoconjugated
form at 1000 WM. Both DCA and CDCA were found
to reduce Neutral red uptake more markedly than
CA and UDCA (Fig. 2). Unconjugated forms of
DCA and CDCA induced stronger toxic e¡ects
than either the tauroconjugated or the glycoconju-
gated forms. These results con¢rm the observations
made in other works on bile acid toxicity using dif-
ferent cell viability tests. Because among the assayed
bile acids DCA showed the strongest ability to re-
duce cell viability, this compound was selected to
perform further studies on the relationship between
toxicity and the bile acid-induced inhibition of DNA
synthesis.
Study of the DCA e¡ect on radiolabeled thymidine
incorporation into DNA revealed the existence of a
bile acid-induced dose-dependent inhibition (Fig. 3).
This e¡ect was signi¢cantly stronger for the un-
conjugated form in comparison with both taurine-
and glycine- amidated forms. The IC50, de¢ned as
the concentration inducing a 50% inhibition of
thymidine incorporation into DNA was GDCA
(610 WM)sTDCA (470 WM)sDCA (260 WM).
Fig. 3. Dose-dependent e¡ect of the unconjugated (open
circles), tauro-conjugated (¢lled squares) and glyco-conjugated
forms (open squares) of deoxycholic acid (DCA) on DNA syn-
thesis as measured by radiolabeled thymidine incorporation into
DNA during 6 h exposure to the indicated bile acid. Values
(means þ S.E., four experiments carried out in triplicate) are ex-
pressed as percent of the mean value found in the control
group (cells cultured in the absence of bile acids). Results were
compared with control culture conditions by the paired t-test
(2P6 0.05) and among bile acids species by the Bonferroni
method of multiple range testing (*P6 0.05).
Fig. 4. Relationship between the inhibitory e¡ects of (A) uncon-
jugated-, (B) tauro-conjugated- and (C) glyco-conjugated-DCA
(open circles) on cell viability and DNA synthesis. Results were
obtained from the data shown in Figs. 2 and 3. Filled circles:
results from hepatocytes cultured in the absence of bile acids.
DCA, deoxycholic acid.
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When the relationship between the e¡ect of DCA
in di¡erent conjugation states on cell viability and
DNA synthesis was studied (Fig. 4), a marked di¡er-
ence in the sensitivity of thymidine incorporation
into DNA and cell viability to these bile acids was
observed. This was particularly evident for the tauro-
conjugated form. More than 50% inhibition in thy-
midine incorporation into DNA was found at con-
centrations lower than that needed to signi¢cantly
a¡ect Neutral red uptake. At higher concentrations,
a slight additional inhibition in thymidine incorpora-
tion into DNA was found but inhibition of Neutral
red uptake was sharply increased. This di¡erential
sensitivity was further investigated using a di¡erent
test to measure cell viability; namely, formazan for-
mation from tetrazolium salts. Fig. 5 shows that
200 WM TDCA induced a signi¢cant inhibition in
thymidine incorporation into DNA with no signi¢-
cant e¡ect on cell viability, regardless of the cell via-
bility test carried out. This inhibition was observed
even in the presence in the culture of the hepatopro-
tective compounds TUDCA (200 WM) or SAMe
(600 WM).
4. Discussion
In previous studies, we have reported that bile
acids are able to modify the rate of active DNA syn-
thesis that occurs in the rodent liver a few hours after
two-thirds partial hepatectomy. This bile acid-in-
duced inhibition seemed to be mediated by mecha-
nisms other than general cell toxicity, which is be-
lieved to be due in part to the detergent action of
amphipathic bile acid molecules on plasma and mi-
tochondrial membranes [8,9].
In the present work, cell viability was investigated
using two di¡erent approaches, i.e. measurement of
the ability of lysosomes and Golgi apparatus to take
up and retain Neutral red [18], and determination of
the ability of microsomes (in the presence of reduced
nucleotides) and, in a lesser extent of mitochondria
(in the presence of succinate) to reduce tetrazolium
salts to formazan [19]. These assays are commonly
used to measure the viability of di¡erent cell types
[23]. In particular, they have been applied by others
to study the cytotoxicity of di¡erent compounds on
rat [24] and human [25] hepatocytes and to check the
e⁄ciency of cryopreservation procedures for these
cells [26]. Using both approaches, the work described
here revealed that the non-toxic concentration range
of the major bile acids for cultured hepatocytes is
similar to that reported by other authors [27^30].
The results on radiolabeled thymidine incorporation
into DNA indicate that bile acid-induced inhibition
of DNA synthesis does not depend on a previous
decrease in cell viability. The functional integrity of
several hepatocyte organelles was maintained as
indicated by the viability tests carried out in the pres-
ence of bile acid concentrations in the culture me-
dium at which a marked decrease in DNA synthesis
was found. This characteristic of bile acids has also
Fig. 5. E¡ect of 200 WM tauroursodeoxycholic acid (TUDCA)
or 600 WM S-adenosylmethionine (SAMe) on 200 WM tauro-
deoxycholic acid (TDCA)-induced inhibition of DNA synthesis
(C). E¡ects on cell viability as measured by two di¡erent meth-
ods: (A) Neutral red uptake; and (B) formazan formation. Val-
ues are means þ S.E. (four experiments carried out in triplicate).
Results were compared with control culture conditions by the
Bonferroni method of multiple range testing (*P6 0.05).
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been observed by other groups for other cell prolif-
eration inhibitors which rapidly and extensively re-
duce radiolabeled thymidine incorporation into
DNA by proliferating cells in culture, while they
fail to decrease cell viability at early times [31,32].
Amidation is known to prevent or signi¢cantly
reduce the cytotoxicity of the more hydrophobic un-
conjugated forms of bile acids, both in hepatocytes
[27^29] and bile duct cells [33]. An interesting obser-
vation supporting the lack of a direct cause^e¡ect
relationship between general cell toxicity and DNA
synthesis inhibition was as follows: our results indi-
cate that, as far as cell viability is concerned, taurine
or glycine amidation of DCA signi¢cantly diminishes
cell toxicity but only slightly reduces the ability to
inhibit DNA synthesis. Additionally, in agreement
with previous in vivo observations [10], both the un-
conjugated and tauroconjugated derivatives were
stronger inhibitors of thymidine incorporation into
DNA than the glycoconjugated derivatives. Finally,
TUDCA [34^36] and S-adenosyl-L-methionine [37]
have been reported to prevent the deleterious e¡ect
to toxic bile acids and other compounds on rat hep-
atocytes with great e⁄ciency. However, in the
present work they were unable to prevent TDCA-
induced DNA inhibition, suggesting that this would
be mediated by a mechanism other than that respon-
sible for bile acid-induced general cell toxicity. Alter-
natively, if bile acids a¡ect organelle functionality
and DNA synthesis machinery by a similar mecha-
nism of action, the latter seems to be more sensitive
than the former. Dual e¡ect of bile acids on liver
cells during cholestasis has been proposed by Benz
et al. [36]. These authors suggested that injury due to
high bile acid concentrations is due to cytolysis,
whereas in moderately severe cholestasis apoptosis
may represent the predominant mechanism of bile
acid toxicity. This is consistent with an e¡ect on
DNA preceding that of general toxicity suggested
by the present work. It is possible that apoptosis
observed by Benz et al. [36] and decreased thymidine
incorporation found by us are part of the same, yet
unknown, hepatocyte complex response to subcyto-
lytic concentrations of bile acids. However, an appar-
ent controversy arises from the fact that a protective
e¡ect of TUDCA was not observed in the present
work, whereas TUDCA was found to reduce bile
acid-induced apoptosis [36] and UDCA has been re-
ported to increased thymidine incorporation by rat
hepatocytes [38]. A major di¡erence between these
studies and our work is that in the previous reports,
bile acid exposure was carried out early after cell
attachment, while in the present work, bile acids
were added to the culture medium 42 h later, when
DNA synthesis was much more active.
In any event, these results indicate that the bile
acid-induced impairment of DNA synthesis does
not require observable decreases in hepatocyte viabil-
ity. This suggests that bile acids may a¡ect the rate
of DNA repair and/or proliferation, which may be of
particular interest regarding the role of bile acids in
the etiology of certain types of cancer.
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